Varex Imaging Corporation (VREX) Financials
VREX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 1.2 billion | 659.3 million |
| 2023-09-30 | 1.2 billion | 668.6 million |
| 2023-06-30 | 1.2 billion | 666.8 million |
| 2023-03-31 | 1.2 billion | 657.9 million |
VREX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -100000 | 3.7 million |
| 2023-09-30 | 41.7 million | 3.4 million |
| 2023-06-30 | 33.5 million | 3.6 million |
| 2023-03-31 | 21.7 million | 3.2 million |
VREX Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-12-31 | -400000 |
| 2023-09-30 | 32.0 million |
| 2023-06-30 | 9.2 million |
| 2023-03-31 | 4.3 million |
VREX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 141.3 million | - | 26.7 million |
| 2023-09-30 | 152.6 million | - | 26.9 million |
| 2023-06-30 | 118.5 million | 441.1 million | 26.8 million |
| 2023-03-31 | 104.4 million | 441.0 million | 21.0 million |
VREX Shares Outstanding
VREX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 10.4 million | 20.5 million | 32.4 million | - |
| 2023-09-30 | 5.4 million | 21.8 million | 31.9 million | - |
| 2023-06-30 | 4.2 million | 20.0 million | 32.1 million | - |
| 2023-03-31 | 5.6 million | 23.0 million | 34.1 million | - |
VREX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 190.0 million | 132.9 million |
| 2023-09-30 | 227.4 million | 149.4 million |
| 2023-06-30 | 232.2 million | 155.9 million |
| 2023-03-31 | 228.2 million | 155.5 million |
VREX
Price: $16.58
52 week price:
Earnings Per Share: 0.99 USD
P/E Ratio: 16.34
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 239000
Ebitda: 21.7 millionMarket Capitalization: 716.9 million